Rosa David J. - Aug 5, 2021 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Business Officer
Signature
By: Donna Spinola For: David J Rosa
Stock symbol
ISRG
Transactions as of
Aug 5, 2021
Transactions value $
-$12,744,733
Form type
4
Date filed
8/9/2021, 06:53 PM
Previous filing
Jun 16, 2021
Next filing
Aug 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $1.81M +10.5K +32.1% $172.44 43.2K Aug 5, 2021 Direct F1
transaction ISRG Common Stock Sale -$8.2M -8.15K -18.85% $1,007.23 35.1K Aug 5, 2021 Direct F1, F2
transaction ISRG Common Stock Options Exercise $1.81M +10.5K +29.94% $172.44 45.6K Aug 6, 2021 Direct F1
transaction ISRG Common Stock Sale -$8.16M -8.07K -17.7% $1,011.90 37.5K Aug 6, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -10.5K -50% $0.00 10.5K Aug 5, 2021 Common Stock 10.5K $172.44 Direct F1, F4
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -10.5K -100% $0.00* 0 Aug 6, 2021 Common Stock 10.5K $172.44 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13, 2022.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $997.81 to $1,009.99, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,007.24 to $1,020.59, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.